Pediatric Hydralazine 1mg/ml Suspension from Japan
Compounded oral suspension at 1mg/ml hydralazine for pediatric hypertensive patients, shaken before use. Put up in measured dose bottles for retail pharmacy, under HTS 3004.90.92.20 as therapeutic cardiovascular mixed product.
Duty Rate — Japan → United States
15%
Rate breakdown
9903.04.6215%Pharmaceuticals: patented pharma from JP/EU/KR/CH/LI — 15% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Stability testing for suspensions critical; include shake-test videos if requested
• Pediatric exclusivity may apply; check FDA Orange Book status